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OBJECTIVE: Published data for the age distribution 
and survival of transfusion patients is either outdated
(Vamvakas, 1994) or non-US based (Mathoulin-Pellisier
2000; Tynell 2001). Vamvakas data were based on a
sample of patients transfused during surgery in Olmsted
county (MN) in 1981. The validity of such data for
current analyses is uncertain given changes in transfusion
practices. This study obtained current estimates of age at
transfusion and survival of transfused patients to popu-
late a cost-effectiveness model of screening volunteer
blood donations.
METHODS: Eligible patients had at least one code (ICD-
9-CM, CPT-4, HCPCS, UB-92) for blood transfusion in
1995 and were eligible for services one month surround-
ing the index transfusion date. Data were from a pro-
prietary managed care database containing private health
care claims and enrollment data representing health care
services provided through various managed care plans to
approximately 3 million members annually, including
Medicare-eligible individuals, in over 20 states. Age dis-
tribution and age-speciﬁc ﬁve-year survival of transfusion
recipients were calculated.
RESULTS: A total of 6,779 patients were included. The
baseline age distribution was: <16 years—4.7%, 16–45
years—14.4%, 46–65 years—21.3% and >65 years—
59.7%. This was similar to the distribution reported 
by Mathoulin-Pelissier, but with a larger proportion of
the population in the older age categories. Annual post-
transfusion mortality was estimated as: Year 1–31%,
Year 2–13%, Year 3–9%, Year 4–9%, and Year 5–8%
(percent of transfused cohort). These post-transfusion
mortality rates are about 5 percentage points greater than
those from the Vamvakas data. These data indicate that
morbidity of patients receiving transfusion in the US may
have risen since 1981; the new data may better represent
general practice across the US.
CONCLUSIONS: Current data conﬁrm that post-
transfusion mortality rates continue to be high, presum-
ably due to patient underlying disease, with over 40%
mortality within the ﬁrst two years of transfusion.
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OBJECTIVE: This research aims to build an information
system on pharmaceutical services, taking into account
patients’ opinions, to assess providers as well as health
care system performance and to provide a market 
surveillance tool, at a time where increasing hazards for
patients emerge from global trade and increased risks 
of counterfeiting and piracy. It also provides guidance 
on prescribing policies for clinical governance and 
policymakers.
METHODS: The patient survey combines patients’ opin-
ions and reported information about drug care, health
status and socio-demographic characteristics. Patients’
opinions are on information, clinical quality, access, com-
munication and trust. Reported information, to assess
system performance, is partly based on Prosper question-
naire from the Center for Quality of Care, HSPH (section
3). A sample of 251 patients was randomly selected, from
computerized patient registers of three practices in a 
UK Primary Care Group on three chronic conditions:
hypertension, asthma and diabetes.
RESULTS: Five rate-based patient satisfaction scores and
several reported scores on drug therapies for three chronic
conditions are presented. Large variations appear among
patient satisfaction scores, but mainly at practice level.
Highest opinion scores of practices are on communica-
tion and lowest scores on access. Around 13% of patient
think they receive confusing information and the rate is
especially high among asthmatic patients. Main sources
of confusion are between professionals and media infor-
mation sources. Reported information provides detailed
insight on areas and forms of confusion (side-effects, how
and when to take medications).
CONCLUSIONS: This paper shows that certain scores
may conﬂict with rational drug use policy and appropri-
ateness of uptake of medicines. Major problems in drug
supply and lack of business ethics challenge providers and
patients. Policy implications of such information system
on drug care will be discussed in order to address increas-
ing hazards for patient safety and pharmaceutical 
services.
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OBJECTIVE: Inappropriate prescribing can cause sig-
niﬁcant adverse events for all age groups. It is perhaps
most challenging and costly when it happens to vulner-
able population groups in general and the elderly in 
particular. Some studies explored the high prevalence and
demographic variables as risk factors of inappropriate
prescribing in the elderly. This study extends to examine
the impact of insurance type on inappropriate drug use
by the elderly.
